Outcome of children with refractory anaemia with excess of blast (RAEB) and RAEB in Transformation (RAEB-T) in the Japanese MDS99 study

British Journal of Haematology

Volumn 158, Issue 5, 2012, Pages 657-661

  Kikuchi, Akira ^a   Hasegawa, Daisuke ^b   Ohtsuka, Yoshitoshi ^c   Hamamoto, Kazuko ^d   Kojima, Seiji ^e   Okamura, Jun ^f   Nakahata, Tatsutoshi ^g   Manabe, Atsushi ^b  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f NATIONAL KYUSHU CANCER CENTER   (Japan)

^g KYOTO UNIVERSITY   (Japan)

Author keywords

Childhood; Haematopoietic stem cell transplantation; Refractory anaemia with excess of blast; Refractory anaemia with excess of blast in transformation

Indexed keywords

CYTARABINE; ETOPOSIDE; MITOXANTRONE;

ADOLESCENT; ARTICLE; CANCER PROGNOSIS; CANCER REGRESSION; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; EVENT FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INDUCTION CHEMOTHERAPY; JAPANESE; KARYOTYPE; MALE; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; REFRACTORY ANEMIA WITH EXCESS BLASTS IN TRANSFORMATION; SCHOOL CHILD; SURVIVAL RATE;

ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CYTARABINE; ETOPOSIDE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MITOXANTRONE; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 84865127747     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09210.x     Document Type: Article

References (14)

1. Chan, G.C., Wang, W.C., Raimondi, S.C., Behm, F.G., Krance, R.A., Chen, G., Freiberg, A., Ingram, L., Butler, D. & Head, D.R. (1997) Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count. Leukemia, 11, 206-211.
2. Creutzig, U., Bender-Gotze, C., Ritter, J., Zimmermann, M., Stollmann-Gibbels, B., Korholz, D. & Niemeyer, C. (1998) The role of intensive AML-specific therapy in treatment of children with RAEB and RAEB-t. Leukemia, 12, 652-659.
3. Gohring, G., Michalova, K., Beverloo, H.B., Betts, D., Harbott, J., Haas, O.A., Kerndrup, G., Sainati, L., Bergstraesser, E., Hasle, H., Stary, J., Trebo, M., van den Heuvel-Eibrink, M.M., Zecca, M., van Wering, E.R., Fischer, A., Noellke, P., Strahm, B., Locatelli, F., Niemeyer, C.M. & Schlegelberger, B. (2010) Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome. Blood, 116, 3766-3769.
4. Hasegawa, D., Manabe, A., Yagasaki, H., Ohtsuka, Y., Inoue, M., Kikuchi, A., Ohara, A., Tsuchida, M., Kojima, S., Nakahata, T. & Japanese Childhood MDS Study Group. (2009) Treatment of children with refractory anemia: the Japanese Childhood MDS Study Group trial (MDS99). Pediatric Blood & Cancer, 53, 1011-1015.
5. Hasle, H., Kerndrup, G., Yssing, M., Clausen, N., Ostergaard, E., Jacobsen, N. & Jacobsen, B.B. (1996) Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia. Leukemia, 10, 1269-1273.
6. Madureira, A.B.M., Eapen, M., Locatelli, F., Teira, P., Zhang, M.J., Davies, S.M., Picardi, A., Woolfrey, A., Chan, K.W., Socié, G., Vora, A., Bertrand, Y., Sales-Bonfim, C.M., Gluckman, E., Niemeyer, C. & Rocha, V. (2011) Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation. Leukemia, 25, 449-454.
7. Niemeyer, C.M. & Kratz, C.P. (2008) Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options. British Journal of Haematology, 140, 610-624.
8. Passmore, S.J., Chessells, J.M., Kempski, H., Hann, I.M., Brownbill, P.A. & Stiller, C.A. (2003) Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population-based study of incidence and survival. British Journal of Haematology, 121, 758-767.
9. Sasaki, H., Manabe, A., Kojima, S., Tsuchida, M., Hayashi, Y., Ikuta, K., Okamura, J., Koike, K., Ohara, A., Ishii, E., Komada, Y., Hibi, S., Nakahata, T. & MDS Committee of the Japanese Society of Pediatric Hematology, Japan. (2001) Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan. Leukemia, 15, 1713-1720.
10. Strahm, B., Nollke, P., Zecca, M., Korthof, E.T., Bierings, M., Furlan, I., Sedlacek, P., Chybicka, A., Schmugge, M., Bordon, V., Peters, C., O'Marcaigh, A., de Heredia1, C.D., Bergstraesser, E., Moerloose, B.D., van den Heuvel-Eibrink, M.M., Stary, J., Trebo, M., Wojcik, D., Niemeyer, C.M., Locatelli, F. & for the EWOG-MDS study group. (2011) Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study. Leukemia, 25, 455-462.
11. Tomizawa, D., Tabuchi, K., Kinoshita, A., Hanada, R., Kigasawa, H., Tsukimoto, I., Tsuchida, M. & Tokyo Children's Cancer Study Group. (2007) Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group. Pediatric Blood & Cancer, 49, 127-132.
12. Tsukimoto, I., Tawa, A., Horibe, K., Tabuchi, K., Kigasawa, H., Tsuchida, M., Yabe, H., Nakayama, H., Kudo, K., Kobayashi, R., Hamamoto, K., Imaizumi, M., Morimoto, A., Tsuchiya, S. & Hanada, R. (2009) Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group. Journal of Clinical Oncology, 27, 4007-4013.
13. Webb, D.K., Passmore, S.J., Hann, I.M., Harrison, G., Wheatley, K. & Chessells, J. (2002) Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99. British Journal of Haematology, 117, 33-39.
14. Woods, W.G., Barnard, D.R., Alonzo, T.A., Buckley, J.D., Kobrinsky, N., Arthur, D.C., Sanders, J., Neudorf, S., Gold, S. & Lange, B.J. (2002) Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the Children's Cancer Group. Journal of Clinical Oncology, 20, 434-440.